ID   CUTO-34
AC   CVCL_C8TA
SY   CUTO34; Colorado University Thoracic Oncology 34
DR   Wikidata; Q123030997
RX   DOI=10.1101/2022.06.08.495301;
CC   Sequence variation: Gene fusion; HGNC; HGNC:427; ALK + HGNC; HGNC:1316; EML4; Name(s)=EML4-ALK; Note=E6A20 v3 fusion (DOI=10.1101/2022.06.08.495301).
CC   Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   46Y
CA   Cancer cell line
DT   Created: 05-10-23; Last updated: 19-12-24; Version: 3
//
RX   DOI=10.1101/2022.06.08.495301;
RA   Licciardello M.P., Zhang C., Le A.T., Doebele R.C., Clarke P.A.,
RA   Workman P.;
RT   "Loss of spindly sensitizes EML4-ALK v3 lung cancer cells to HSP90
RT   inhibitors.";
RL   bioRxiv 2022:06.08.495301-06.08.495301(2022).
//